 period should be individualized. In a metaanalysis of three randomized clinical trials including
36,881 patients undergoing CEA, dual antiplatelet therapy was not associated with reduced risk of perioperative stroke, TIA, or death, but it was associated with
increased risk of neck hematoma and major bleeding
complications.164 Conversely, in a review of 10,46 patients undergoing vascular surgerydincluding 5264 undergoing CEAdthere